Differences in cardiopulmonary exercise test results by American Thoracic Society/European Respiratory Society-Global Initiative for Chronic Obstructive Lung Disease stage categories and gender.

BACKGROUND The American Thoracic Society (ATS)/European Respiratory Society (ERS)-Global Initiative for Chronic Obstructive Lung Disease (GOLD) has developed a new staging system based on the degree of airflow obstruction. Its validity to predict exercise capacity as an outcome has not been extensively studied. We hypothesized that exercise performance measured by cardiopulmonary exercise test (CPET) results should decline significantly with each disease stage, independent of gender. METHODS We examined 453 consecutive incremental CPET and pulmonary function tests performed in patients who had been referred to a single respiratory physiology laboratory in a tertiary care hospital. They were divided into a control group (normal lung function) and ATS/ERS-GOLD stages 1 to 4. We measured anthropometrics, peak work (in watts), peak oxygen uptake (in liters per kilogram per minute and percent predicted), breathing reserve (in percent predicted), and arterial blood gas response. We compared these results between different stages and genders. RESULTS The mean (+/- SD) age for the entire group was 64 +/- 11 years, the mean FEV(1) was 66 +/- 28%, and the mean body mass index (BMI) was 27.2 +/- 5.82 kg/m(2). Patients in stage 4 were significantly younger (p < 0.001) and had a lower BMI (p < 0.02) compared to those in stages 1 to 3. There was a significant reduction in exercise capacity for patients at every stage except for those in stage 1, who had values similar to those of the control group. Women had better lung function and exercise capacity than men, but the difference disappeared when adjusted by COPD stages. CONCLUSIONS The ATS/ERS-GOLD staging system can be used to indicate differences in exercise capacity in patients with COPD stages 2 to 4 and to normalize apparent gender disparities. The value of differentiating stage 1 patients requires further studies with different outcomes.

[1]  J. Erikssen,et al.  Can global initiative for Chronic Obstructive Lung Disease stage 0 provide prognostic information on long-term mortality in men? , 2006, Chest.

[2]  B. Celli,et al.  Gender and COPD in patients attending a pulmonary clinic. , 2006, Chest.

[3]  B. Celli,et al.  Gender and COPD in Patients Attending a Pulmonary Clinic , 2005 .

[4]  A. Lindberg,et al.  Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. , 2005, Chest.

[5]  E. Tolley,et al.  Qualitative Methods in Public Health: A Field Guide for Applied Research , 2004 .

[6]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[7]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[8]  B. Celli,et al.  The 6‐min walk distance: change over time and value as a predictor of survival in severe COPD , 2004, European Respiratory Journal.

[9]  R. Ross,et al.  ATS/ACCP statement on cardiopulmonary exercise testing. , 2003, American journal of respiratory and critical care medicine.

[10]  D. Mannino,et al.  Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study , 2003, Thorax.

[11]  F. Martinez,et al.  American Thoracic Society/ American College of Chest Physicians ATS/ACCP Statement on Cardiopulmonary Exercise Testing , 2003 .

[12]  D. O’Donnell,et al.  Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. , 2002, American journal of respiratory and critical care medicine.

[13]  J. Dempsey.  Exercise carbon dioxide retention in chronic obstructive pulmonary disease: a case for ventilation/perfusion mismatch combined with hyperinflation. , 2002, American journal of respiratory and critical care medicine.

[14]  A. Buist.  Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.

[15]  J. Vestbo,et al.  Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? , 2002, American journal of respiratory and critical care medicine.

[16]  Toru Oga,et al.  Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. , 2002, Chest.

[17]  Karlman Wasserman,et al.  Principles of Exercise Testing & Interpretation: Including Pathophysiology and Clinical Applications , 1999 .

[18]  B. Celli,et al.  Mouth occlusion pressure, CO2 response and hypercapnia in severe chronic obstructive pulmonary disease. , 1998, The European respiratory journal.

[19]  R. Carter,et al.  Differing effects of airway obstruction on physical work capacity and ventilation in men and women with COPD. , 1994, Chest.

[20]  J. Elashoff,et al.  Prediction of maximal exercise capacity in obstructive and restrictive pulmonary disease. , 1993, Chest.

[21]  B. Dawson-Saunders,et al.  Basic and Clinical Biostatistics , 1993 .

[22]  David B. Holiday,et al.  Altered Exercise Gas Exchange and Cardiac Function in Patients with Mild Chronic Obstructive Pulmonary Disease , 1993 .

[23]  P. Wagner,et al.  Ventilation-perfusion matching during exercise. , 1992, Chest.

[24]  J. Barberà,et al.  Gas exchange during exercise in mild chronic obstructive pulmonary disease. Correlation with lung structure. , 1991, The American review of respiratory disease.

[25]  J. Barberà,et al.  Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. , 1990, Chest.

[26]  G. D'Alonzo,et al.  The effect of exercise on pulmonary gas exchange in patients with severe chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[27]  R. Marthan,et al.  Gas exchange alterations in patients with chronic obstructive lung disease. , 1985, Chest.